BRCA1 and neoplasm: However, the BRCA1-like tumours show a significantly better recurrence-free survival after intensive chemotherapy than after conventional dose chemotherapy (Figure 1B, D) (P = 0.002 for aCGH and P = 0.024 for MLPA).